
With patients buying gray-market peptides, HHS’s draft policy aims to reunite prescribers, patients, and pharmacists around these emerging products.
Several community pharmacy groups will be seeking Medicare's approval of a discount drug card program they are developing to benefit enrollees and help pharmacies stay solvent.






